RNPEX
Price
$66.67
Change
-$0.16 (-0.24%)
Updated
Dec 17 closing price
RPEBX
Price
$65.85
Change
-$0.16 (-0.24%)
Updated
Dec 17 closing price
Ad is loading...

RNPEX vs RPEBX

Header iconRNPEX vs RPEBX Comparison
Open Charts RNPEX vs RPEBXBanner chart's image
American Funds New Perspective R4
Price$66.67
Change-$0.16 (-0.24%)
VolumeN/A
CapitalizationN/A
American Funds New Perspective R2E
Price$65.85
Change-$0.16 (-0.24%)
VolumeN/A
CapitalizationN/A
RNPEX vs RPEBX Comparison Chart
Loading...
View a ticker or compare two or three
VS
RNPEX vs. RPEBX commentary
Dec 19, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is RNPEX is a Buy and RPEBX is a Buy.

FUNDAMENTALS
Fundamentals
RNPEX (149B) and RPEBX (149B) have equal amount of cash in the bank . RNPEX pays higher dividends than RPEBX: RNPEX (0.83) vs RPEBX (0.46). RNPEX was incepted earlier than RPEBX: RNPEX (23 years) vs RPEBX (10 years). RNPEX (17.00) and RPEBX (17.00) have comparable annual turnover. RNPEX (250) and RPEBX (250) have matching initial minimum investment requirements. RNPEX (23.10) and RPEBX (22.56) have marching annual gain over last year. RNPEX (40.88) and RPEBX (38.90) have equivalent 5 years return.
RNPEXRPEBXRNPEX / RPEBX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence23 years10 years-
Gain YTD21.48320.981102%
Front LoadN/AN/A-
Min. Initial Investment250250100%
Min. Initial Investment IRAN/AN/A-
Net Assets149B149B100%
Annual Yield % from dividends0.830.46180%
Returns for 1 year23.1022.56102%
Returns for 3 years7.226.18117%
Returns for 5 years40.8838.90105%
Returns for 10 years76.0571.21107%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CHD105.80-0.02
-0.02%
Church & Dwight Co
BZH30.01-0.61
-1.99%
Beazer Homes USA
ESEA34.12-0.76
-2.18%
Euroseas Ltd
BHVN39.12-2.32
-5.60%
Biohaven Ltd
NXTC0.90-0.11
-10.82%
NextCure